Enviro-Serv (PINKSHEETS:EVSV), the parent and publicly traded vehicle of Enviro-Serv USA has announced a 260 million share reduction in outstanding and floating EVSV common stock shares has commenced exploratory meetings with former organic fertilizer and pesticide manufacturers for potential entry into the marijuana sector.
As quoted in the press release:

Chris Trina, Chairman and CEO, had these exciting remarks for the investing public about the booming cannabis market, “One does not need to be a rocket scientist to understand the upside potential within the cannabis space as the growth projections continue to soar. In 2016 Fortune magazine estimated legal marijuana sales of over 6.5 billion dollars with growth estimates ranging from 25-30% through 2017. Many industries are feeding off this frenzy in their quest to capture their own slice of the pie. It has been publicly documented in a Forbes article dated July 6th, 2016 that the CEO of Scotts Miracle-Gro intends to invest over 500 million dollars and he was quoted in the same article to say, ‘It’s the biggest thing I’ve ever seen in lawn and garden.'”
Trina went on to exclaim, “The time is now for us to seriously explore our own opportunities. I feel strongly about my knowledge and sources of contacts within the insecticide/fertilization market to penetrate and capture some of this industry growth from within this arena. In 2008 and 2009 my former subsidiary, Organic Products International which hit sales of over one million dollars in those years, had multiple licensing/distribution agreements with two giants in the eco-friendly organic fertilizer space. Although the recession of 2008-2010 killed our momentum these relationships are still ripe and just yesterday I had a successful phone conference with my former Georgia-based joint venture partner which was highly encouraging. I believe we can create a niche market where we aren’t directly competing against the Scotts of the world and successfully earn our fair share. Although this is currently exploratory in nature Enviro-Serv will be reviving this subsidiary under the same well branded name, OPI, to better prepare for these ongoing forward looking opportunities.”

Click here to read the full press release.

Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry

Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that effective January 4, 2021, it entered into a lab services agreement with Numinus Wellness Inc. (“Numinus“). Recognized as an early leader in developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), Numinus is aiding Optimi’s mission to further the research and development of Canadian-grown psilocybin-producing mushrooms and related product formulations.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to provide shareholders with the following corporate update:

Nextleaf Comments on Financial Results from Q1 Financials

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”) reported its second quarter results for the period ended December 31, 2020. A complete set of financial statements and Management’s Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.

The second quarter of FY21, saw continued momentum for the Company despite ongoing pandemic related challenges. Net revenue grew 8% to $745,748 from $689,276 versus the same quarter year ago. The Company also saw significant improvement on its bottom line, reducing its net loss by 50% from ($.956) million to ($.481) million, year over year for the quarter, as a result of improved gross margin and cost management efforts. On December 9, 2020, the company announced the closing of the acquisition of substantially all of the assets of Lexaria Canpharm (“Canpharm“), the cannabis products division of Lexaria Biosciences, resulting in the addition of a new B2B Line of Business.

Keep reading... Show less

Royalty Model Provides Access to Early Stage Licenced U.S. Cannabis Companies and Leverage to High-Margin Revenues

FinCanna Capital Corp. (“FinCanna” or the “Company”) (CSE:CALI), a royalty company for the licensed U.S. cannabis industry, is pleased to provide a corporate update further to its recently announced upsized financing of $2 million

Keep reading... Show less

Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or alcohol use disorders enters pre-implementation stage

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), and Syreon Corporation (Syreon), a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access 1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. Currently in the development stage, the PRIME study will assess the efficacy and safety of psilocybin-assisted motivational enhancement therapy.

Keep reading... Show less